2025 Oncology Institute
April 19, 2025 | 8:16 PM EST
- Home
- Clinical Resources Search
- PQI in Action: Extolling the Benefits of Identifying Polycythemia Vera Patients and Myelofibrosis within Medically Integrated Dispensing Practices
Extolling the Benefits of Identifying Polycythemia Vera Patients and Myelofibrosis within Medically Integrated Dispensing Practices
Download PQI pdf 4.94MB
Last Updated: October 1, 2018
By: New England Cancer Specialists, ME | Utah Cancer Specialists, UT
About this PQI in Action
In effort to promote higher quality patient care the National Community Oncology Dispensing Association, Inc (NCODA) constructed the NCODA Positive Quality Intervention to provide healthcare providers with the support and enhanced education to improve the overall management of patients receiving oral oncolytics. The PQI fosters better care for patients through increased speed to therapy, reduced cost and hospitalization, and by improving persistence and adherence within medically integrated teams.
More About This PQI in Action
Find a PQIPQI in Action
PQI in Action: Ropeginterferon alfa-2b-njft (BESREMi®) Use in Polycythemia Vera
Last Updated: October 1, 2023
PQI
PQI: Ruxolitinib (Jakafi®): Managing Treatment of Polycythemia Vera
Last Updated: April 29, 2024